Draft Standards and Best Practices for Interaction Between Medical Examiner/Coroner and Organ and Tissue Procurement Organizations, 24537 [2012-9842]
Download as PDF
<![CDATA[
Federal Register / Vol. 77, No. 79 / Tuesday, April 24, 2012 / Notices
mstockstill on DSK4VPTVN1PROD with NOTICES
communication, the date, time, and
duration of the communication, the
medium of the communication, and a
description of the subject matter of the
communication (for a collection of
communications solely concerning a
single business arrangement that is
specifically exempted from the
reporting requirements of Section IV.C
of this Final Judgment, the Settling
Defendant may provide a summary of
the communications rather than logging
each communication individually); and
J. Providing to the Department of
Justice annually, on or before the
anniversary of the entry of this Final
Judgment, a written statement as to the
fact and manner of the Settling
Defendant’s compliance with Sections
IV, V, and VII of this Final Judgment.
VIII. Compliance Inspection
A. For purposes of determining or
securing compliance with this Final
Judgment, or of determining whether
the Final Judgment should be modified
or vacated, and subject to any legally
recognized privilege, from time to time
duly authorized representatives of the
Department of Justice, including
consultants and other persons retained
by the Department of Justice, shall,
upon written request of an authorized
representative of the Assistant Attorney
General in charge of the Antitrust
Division, and on reasonable notice to
Settling Defendants, be permitted:
1. Access during the Settling
Defendants’ office hours to inspect and
copy, or at the option of the United
States, to require Settling Defendants to
provide to the United States hard copy
or electronic copies of all books, ledgers,
accounts, records, data, and documents
in the possession, custody, or control of
Settling Defendants, relating to any
matters contained in this Final
Judgment; and
2. To interview, either informally or
on the record, the Settling Defendants’
officers, employees, or agents, who may
have their individual counsel present,
regarding such matters. The interviews
shall be subject to the reasonable
convenience of the interviewee and
without restraint or interference by
Settling Defendants.
B. Upon the written request of an
authorized representative of the
Assistant Attorney General in charge of
the Antitrust Division, Settling
Defendants shall submit written reports
or respond to written interrogatories,
under oath if requested, relating to any
of the matters contained in this Final
Judgment as may be requested. Written
reports authorized under this paragraph
may, in the sole discretion of the United
States, require Settling Defendants to
VerDate Mar<15>2010
17:40 Apr 23, 2012
Jkt 226001
conduct, at their cost, an independent
audit or analysis relating to any of the
matters contained in this Final
Judgment.
C. No information or documents
obtained by the means provided in this
Section shall be divulged by the United
States to any person other than an
authorized representative of the
executive branch of the United States,
except in the course of legal proceedings
to which the United States is a party
(including grand jury proceedings), or
for the purpose of securing compliance
with this Final Judgment, or as
otherwise required by law.
D. If at the time information or
documents are furnished by a Settling
Defendant to the United States, the
Settling Defendant represents and
identifies in writing the material in any
such information or documents to
which a claim of protection may be
asserted under Rule 26(c)(1)(G) of the
Federal Rules of Civil Procedure, and
the Settling Defendant marks each
pertinent page of such material,
‘‘Subject to claim of protection under
Rule 26(c)(1)(G) of the Federal Rules of
Civil Procedure,’’ then the United States
shall give the Settling Defendant ten
calendar days notice prior to divulging
such material in any civil or
administrative proceeding.
IX. Retention of Jurisdiction
This Court retains jurisdiction to
enable any party to apply to this Court
at any time for further orders and
directions as may be necessary or
appropriate to carry out or construe this
Final Judgment, to modify any of its
provisions, to enforce compliance, and
to punish violations of its provisions.
X. No Limitation on Government Rights
Nothing in this Final Judgment shall
limit the right of the United States to
investigate and bring actions to prevent
or restrain violations of the antitrust
laws concerning any past, present, or
future conduct, policy, or practice of the
Settling Defendants.
XI. Expiration of Final Judgment
Unless this Court grants an extension,
this Final Judgment shall expire five
years from the date of its entry.
XII. Public Interest Determination
Entry of this Final Judgment is in the
public interest. The parties have
complied with the requirements of the
Antitrust Procedures and Penalties Act,
15 U.S.C. 16, including making copies
available to the public of this Final
Judgment, the Competitive Impact
Statement, and any comments thereon
and the United States’ responses to
PO 00000
Frm 00083
Fmt 4703
Sfmt 9990
24537
comments. Based upon the record
before the Court, which includes the
Competitive Impact Statement and any
comments and response to comments
filed with the Court, entry of this Final
Judgment is in the public interest.
Date: llllllllllllllll
Court approval subject to procedures set
forth in the Antitrust Procedures and
Penalties Act, 15 U.S.C. 16
llllllllll
United States District Judge
[FR Doc. 2012–9831 Filed 4–23–12; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Office of Justice Programs
[OJP (NIJ) Docket No. 1589]
Draft Standards and Best Practices for
Interaction Between Medical Examiner/
Coroner and Organ and Tissue
Procurement Organizations
AGENCY:
National Institute of Justice,
DOJ.
Notice and request for
comments.
ACTION:
In an effort to obtain
comments from interested parties, the
U.S. Department of Justice, Office of
Justice Programs, National Institute of
Justice, Scientific Working Group for
Medicolegal Death Investigation will
make available to the general public a
document entitled, ‘‘Organ and Tissue
Procurement Committee Standards and
Best Practices for Interaction Between
Medical Examiner/Coroner Offices and
Organ Tissue Procurement
Organizations’’. The opportunity to
provide comments on this document is
open to coroner/medical examiner office
representatives, law enforcement
agencies, organizations, and all other
stakeholders and interested parties.
Those individuals wishing to obtain and
provide comments on the draft
document under consideration are
directed to the following Web site:
https://www.swgmdi.org.
DATES: Comments must be received on
or before May 12, 2012.
FOR FURTHER INFORMATION CONTACT:
Patricia Kashtan, by telephone at 202–
353–1856 [Note: this is not a toll-free
telephone number], or by email at
Patricia.Kashtan@usdoj.gov.
SUMMARY:
John H. Laub,
Director, National Institute of Justice.
[FR Doc. 2012–9842 Filed 4–23–12; 8:45 am]
BILLING CODE 4410–18–P
E:\FR\FM\24APN1.SGM
24APN1
]]>Agencies
[Federal Register Volume 77, Number 79 (Tuesday, April 24, 2012)]
[Notices]
[Page 24537]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-9842]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Office of Justice Programs
[OJP (NIJ) Docket No. 1589]
Draft Standards and Best Practices for Interaction Between
Medical Examiner/Coroner and Organ and Tissue Procurement Organizations
AGENCY: National Institute of Justice, DOJ.
ACTION: Notice and request for comments.
-----------------------------------------------------------------------
SUMMARY: In an effort to obtain comments from interested parties, the
U.S. Department of Justice, Office of Justice Programs, National
Institute of Justice, Scientific Working Group for Medicolegal Death
Investigation will make available to the general public a document
entitled, ``Organ and Tissue Procurement Committee Standards and Best
Practices for Interaction Between Medical Examiner/Coroner Offices and
Organ Tissue Procurement Organizations''. The opportunity to provide
comments on this document is open to coroner/medical examiner office
representatives, law enforcement agencies, organizations, and all other
stakeholders and interested parties. Those individuals wishing to
obtain and provide comments on the draft document under consideration
are directed to the following Web site: https://www.swgmdi.org.
DATES: Comments must be received on or before May 12, 2012.
FOR FURTHER INFORMATION CONTACT: Patricia Kashtan, by telephone at 202-
353-1856 [Note: this is not a toll-free telephone number], or by email
at Patricia.Kashtan@usdoj.gov.
John H. Laub,
Director, National Institute of Justice.
[FR Doc. 2012-9842 Filed 4-23-12; 8:45 am]
BILLING CODE 4410-18-P
